Drugs off-patent

Drugs Off-Patent Report - less than 100 m Electronic
Reports on Disk
Reports on
Year of Expiration - 1998
Earliest
Class 1 -<10m ; Class 2 -<25m ; Class 3 -<50m ; Class 4 -<75m ; Class 5 -<100m Class 6 ->100m
Drugs Off-Patent Report - less than 100 m Drugs Off-Patent Report - less than 100 m Year of Expiration - 1998
Earliest
Drugs Off-Patent Report - less than 100 m Drugs Off-Patent Report - less than 100 m Year of Expiration – 1998
Earliest
Class 1 -<10m ; Class 2 -<25m ; Class 3 -<50m ; Class 4 -<75m ; Class 5 -<100m Class 6 ->100m
Drugs Off-Patent Report - less than 100 m Drugs Off-Patent Report - less than 100 m Year of Expiration - 1999
Earliest
4-167-574
12/16/99
Drugs Off-Patent Report - less than 100 m Drugs Off-Patent Report - less than 100 m Year of Expiration – 1999
Earliest
12/21/99
12/21/99
12/21/99
12/22/99
12/31/99
Class 1 -<10m ; Class 2 -<25m ; Class 3 -<50m ; Class 4 -<75m ; Class 5 -<100m Class 6 ->100m
Drugs Off-Patent Report - less than 100 m Drugs Off-Patent Report - less than 100 m Year of Expiration - 2000
Under $100 million USD
Earliest
06/08/08
02/02/00
4-892-741
01/02/00
01/02/00
4-309-432
10/04/05
02/07/00
4-690-825
02/26/00
06/14/04
03/13/00
4-680-399
03/24/00
03/24/00
4-258-062
04/03/00
04/03/00
4-219-559
07/14/00
07/14/00
4-278-689
07/21/00
07/28/00
07/29/00
07/29/00
4-301-146
08/18/00
10/15/00
10/15/00
4-283-408
11/26/00
02/16/00
02/16/00
4-146-719
05/31/00
09/13/00
4-386-104
10/03/00
10/03/00
4-344-949
12/29/00
Class 1 -<10m ; Class 2 -<25m ; Class 3 -<50m ; Class 4 -<75m ; Class 5 -<100m USD $
Drugs Off-Patent Report - less than 100 m Drugs Off-Patent Report - less than 100 m Year of Expiration – 2001
Under $100 million USD
Earliest
02/02/01
02/02/01
4-313-951
03/06/01
03/06/01
4-220-660
03/10/01
03/10/01
04/10/01
05/31/01
05/31/01
4-717-720
08/07/01
08/07/01
/A4-464-378
09/06/01
09/06/01
09/06/01
09/06/01
09/18/01
06/21/99
09/18/01
4-472-382
09/19/01
09/19/01
10/26/01
10/26/01
11/09/01
11/09/01
4-358-449
11/20/01
11/20/01
11/27/01
11/27/01
05/13/01
05/13/01
4-439-423
08/10/01
08/10/01
4-390-531
09/18/01
09/18/01
4-472-393
09/18/01
07/12/98
09/18/01
4-472-380
12/20/01
12/21/01
4-454-152
Class 1-<10m ; Class 2-<25m ; Class 3-<50m ; Class 4-<75m ; Class 5-<100m Class 6->100m USD $
Drugs Off-Patent Report - less than 100 m Drugs Off-Patent Report - less than 100 m Year of Expiration - 2002
Under $100 million USD
Earliest
05/07/02
05/07/02
4-515-805
06/07/02
06/07/02
4-387-089
08/23/02
08/23/02
4-400-358
09/27/02
09/27/02
4-406-906
10/18/02
10/18/02
4-518-584
10/21/02
05/03/97
10/21/02
4-395-403
11/21/99
01/12/02
4-263-432
03/05/02
09/14/00
03/05/02
4-503-067
03/14/02
03/14/02
02/18/09
06/13/02
06/13/02
5-089-509
07/02/02
12/23/01
07/02/02
4-526-892
07/08/02
12/23/99
07/08/02
4-307-100
07/15/02
07/15/02
08/20/02
08/20/02
4-536-516
09/11/02
09/11/02
10/02/02
05/09/99
10/02/02
4-375-547
11/12/02
11/12/02
4-537-883
Drugs Off-Patent Report - less than 100 m Drugs Off-Patent Report - less than 100 m Year of Expiration – 2002
Earliest
10/06/06
12/22/02
12/22/02
5-216-167
12/23/02
12/23/02
12/30/02
12/30/02
4-396-598
Note: Some Brand leader drugs products have been omitted due to
non- availability of sales data which will appear in the 2000/2001 report
Class 1 -<10m ; Class 2 -<25m ; Class 3 -<50m ; Class 4 -<75m ; Class 5 -<100m Class 6 ->100m
Drugs Off-Patent Report - less than 100 m Drugs Off-Patent Report - less than 100 m Year of Expiration - 2003
Under $100 million USD
Earliest
02/24/03
04/18/98
4-357-324
02/24/03
06/03/03
06/03/03
4-593-119
06/05/03
06/05/03
4-452-745
08/21/03
08/21/03
4-466-972
08/21/03
08/21/03
4-466-972
09/11/03
12/29/99
09/11/03
4-470-972
01/07/03
01/07/03
4-563-184
11/04/03
11/04/03
4-620-974
02/20/03
02/20/03
04/30/03
04/30/03
05/12/ 03
4-552-899
05/12/03
05/13/03
05/13/03
4-489-070
12/09/03
12/09/03
4-489-071
05/10/00
05/22/03
05/22/03
4-382-892
07/17/03
07/17/03
07/29/03
12/28/98
07/29/03
4-603-146
08/12/03
08/12/03
4-410-521
08/23/03
08/23/03
Drugs Off-Patent Report - less than 100 m Drugs Off-Patent Report - less than 100 m Year of Expiration – 2003
Earliest
09/26/03
12/24/01
09/26/03
4-513-006
10/18/03
10/18/03
11/14/03
11/14/03
4-335-121
12/20/03
12/20/03
Note: Some Brand leader drugs products have been omitted due to
non-availability of sales data which will appear in the 2000/2001 report
Class 1 -<10m ; Class 2 -<25m ; Class 3 -<50m ; Class 4 -<75m ; Class 5 -<100m Class 6 ->100m
Drugs Off-Patent Report - less than 100 m Drugs Off-Patent Report - less than 100 m Year of Expiration - 2004
Under $100 million USD
Earliest
04/14/04
04/14/04
4-658-021
06/02/04
03/30/01
06/02/04
4-670-444
06/16/04
06/16/04
4-673-563
06/19/04
06/19/04
4-584-305
08/04/04
08/04/04
4-559-330
02/10/04
02/10/04
4-642-384
05/12/04
05/12/04
4-664-107
08/11/04
08/11/04
08/25/04
02/27/02
08/25/04
4-689-338
10/01/04
10/01/04
4-579-855
10/10/04
10/10/04
4-316-839
10/31/04
10/31/04
12/02/04
11/10/98
12/02/04
4-369-184
12/17/04
12/17/04
4-619-921
12/18/04
09/23/00
12/18/04
4-587-252
12/22/04
12/22/04
Note: Some Brand leader drugs products have been omitted due to non-
availability of sales data which will appear in the 2000/2001 report
Class 1 -<10m ; Class 2 -<25m ; Class 3 -<50m ; Class 4 -<75m ; Class 5 -<100m Class 6 ->100m
Drugs Off-Patent Report - less than 100 m Drugs Off-Patent Report - less than 100 m Under $100 million USD
Earliest
02/16/05
02/16/05
4-867-982
03/06/05
12/08/97
03/06/05
4-701-460
01/17/05
01/17/98
01/17/05
4-529-593
07/01/05
07/01/98
07/01/05
4-397-839
01/04/05
12/22/99
01/04/05
4-303-651
02/11/05
02/11/05
03/06/05
05/10/00
03/06/05
4-364-921
04/06/05
11/30/00
04/06/05
4-379-785
05/01/05
05/01/05
4-671-953
06/24/05
10/27/98
06/24/05
4-642-346
07/03/05
04/16/00
07/03/05
4-677-191
10/07/05
12/27/99
10/07/05
4-703-038
10/18/05
10/18/05
4-778-676
Class 1 -<10m ; Class 2 -<25m ; Class 3 -<50m ; Class 4 -<75m ; Class 5 -<100m Class 6 ->100m
Drugs Off-Patent Report - less than 100 m Drugs Off-Patent Report - less than 100 m Year of Expiration - 2006
Under $100 million USD
Earliest
01/22/06
01/22/97
01/22/06
4-761-418
01/30/06
01/30/97
01/30/06
4-730-000
08/21/06
12/30/98
08/21/06
4-508-729
08/29/06
08/29/06
4-861-760
08/29/06
08/29/06
4-861-759
10/02/06
10/01/00
10/02/06
4-474-787
06/06/06
06/06/06
4-837-378
09/19/06
04/15/02
09/19/06
4-868-216
09/26/06
12/10/97
09/26/06
4-870-105
12/05/06
11/16/06
12/05/06
4-885-363
12/12/06
07/01/02
12/12/06
4-866-812
Note: Some Brand leader drugs products have been omitted due to
non-availability of sales data which will appear in the 1999/2001 report.
Class 1 -<10m ; Class 2 -<25m ; Class 3 -<50m ; Class 4 -<75m ; Class 5 -<100m Class 6 ->100m
Drugs Off-Patent Report - less than 100 m Drugs Off-Patent Report - less than 100 m Year of Expiration - 2007
Under $100 million USD
Earliest
12/29/07
03/03/00
12/29/07
4-866-048
07/13/07
07/13/07
4-588-585
01/23/07
05/20/99
01/23/07
4-767-612
02/02/07
09/18/97
02/02/07
4-762-856
02/27/07
09/06/00
02/27/07
4-904-769
03/04/07
03/04/07
4-406-899
03/13/07
02/14/99
03/13/07
4-907-583
05/04/07
01/08/98
05/04/07
4-687-659
06/12/07
06/12/07
4-933-168
06/12/07
04/26/01
06/12/07
4-933-361
06/12/07
06/12/07
4-933-168
08/05/07
08/05/03
08/05/07
4-925-860
11/10/07
06/20/02
11/10/07
4-808-605
12/25/07
12/25/07
4-980-173
Note: Some Brand leader drugs products have been omitted due to
non-availability of sales data which will appear in the 2000/2001 report
Class 1 -<10m ; Class 2 -<25m ; Class 3 -<50m ; Class 4 -<75m ; Class 5 -<100m Class 6 ->100m
Drugs Off-Patent Report - less than 100 m Drugs Off-Patent Report - less than 100 m Year of Expiration - 2008
Under $100 million USD
Earliest
03/03/08
03/03/08
4-882-452
11/23/08
11/23/99
11/23/08
5-279-811
03/26/08
03/25/97
03/26/08
4-650-807
04/17/08
09/04/07
04/17/08
4-695-590
07/02/08
06/19/97
07/02/08
5-028-595
04/28/08
12/09/99
04/28/08
4-797-413
05/19/08
09/19/02
05/19/08
4-854-860
07/09/08
07/09/08
5-326-758
08/12/08
02/10/03
08/12/08
4-997-841
11/18/08
11/18/99
11/18/08
4-997-651
Note: Some Brand leader drugs products have been omitted due to
non-availability of sales data which will appear in the 2000/2001 report
Class 1 -<10m ; Class 2 -<25m ; Class 3 -<50m ; Class 4 -<75m ; Class 5 -<100m Class 6 ->100m
Drugs Off-Patent Report - less than 100 m Drugs Off-Patent Report - less than 100 m Year of Expiration - 2009
Under $100 million USD
Earliest
10/19/09
10/19/09
5-114-948
02/15/09
07/12/01
02/15/09
5-019-583
01/17/09
06/26/02
01/17/09
5-006-530
01/19/09
01/19/09
4-895-726
08/15/09
01/05/06
08/15/09
4-981-874
11/17/09
11/01/01
11/17/09
5-164-194
12/08/09
12/08/00
12/08/09
5-169-849
12/27/09
12/27/00
12/27/09
4-935-437
10/06/09
10/06/09
5-152-997
Note: Some Brand leader drugs products have been omitted due to
non-availability of sales data which will appear in the 2000/2001 report.
Class 1 -<10m ; Class 2 -<25m ; Class 3 -<50m ; Class 4 -<75m ; Class 5 -<100m Class 6 ->100m
Drugs Off-Patent Report - less than 100 m Drugs Off-Patent Report - less than 100 m Year of Expiration - 2010
Under $100 million USD
Earliest
04/13/10
07/03/99
04/13/10
5-202-128
09/28/10
08/30/01
09/28/10
5-248-492
05/18/10
05/18/10
4-517-199
05/28/10
05/28/01
05/28/10
5-004-758
06/29/10
03/05/02
06/29/10
5-223-261
11/19/10
12/06/00
11/19/10
5-196-438
12/18/10
12/18/01
12/18/10
5-116-863
Note: Some Brand leader drugs products have been omitted due to
non-availability of sales data which will appear in the 2000/2001 report.
Class 1 -<10m ; Class 2 -<25m ; Class 3 -<50m ; Class 4 -<75m ; Class 5 -<100m Class 6 ->100m
Drugs Off-Patent Report - less than 100 m Drugs Off-Patent Report - less than 100 m Year of Expiration - 2011
Under $100 million USD
Earliest
06/11/11
06/11/11
4-234-571
09/20/11
03/22/01
09/20/11
5-349-085
03/20/11
09/30/02
03/20/11
5-270-317
03/20/11
09/29/00
03/20/11
10/16/11
10/16/11
5-164-194
11/22/11
06/21/01
11/22/11
5-366-972
Note: Some Brand leader drugs products have been omitted due to
non-availability of sales data which will appear in the 2000/2001 report.
Class 1 -<10m ; Class 2 -<25m ; Class 3 -<50m ; Class 4 -<75m ; Class 5 -<100m Class 6 ->100m
Drugs Off-Patent Report - less than 100 m Drugs Off-Patent Report - less than 100 m Year of Expiration - 2012
Under $100 million USD
Earliest
08/01/12
12/27/00
08/01/12
5-438-071
05/21/12
06/26/00
05/21/12
5-716-641
03/24/12
09/30/02
03/24/12
06/20/12
06/20/12
12/19/12
01/29/03
12/19/12
5-476-875
11/19/12
12/06/00
11/19/12
5-196-438
03/21/12
12/23/01
03/21/12
5-399-578
09/26/12
12/15/98
09/26/12
5-453-510
Note: Some Brand leader drugs products have been omitted due to
non-availability of sales data which will appear in the 2000/2001 report.
Class 1 -<10m ; Class 2 -<25m ; Class 3 -<50m ; Class 4 -<75m ; Class 5 -<100m Class 6 ->100m
Drugs Off-Patent Report - less than 100 m Drugs Off-Patent Report - less than 100 m Year of Expiration - 2013
Under $100 million USD
Earliest
08/28/13
05/23/01
08/28/13
5-549-892
05/07/13
06/14/01
05/07/13
5-514-646
10/08/13
11/06/02
10/08/13
5-563-183
09/15/13
07/13/00
09/15/13
5-543-150
10/15/13
12/19/00
10/15/13
5-547-957
Note: Some Brand leader drugs products have been omitted due to
non-availability of sales data which will appear in the 2000/2001 report.
Class 1 -<10m ; Class 2 -<25m ; Class 3 -<50m ; Class 4 -<75m ; Class 5 -<100m Class 6 ->100m
Drugs Off-Patent Report - less than 100 m Drugs Off-Patent Report - less than 100 m D r u g s Off-Patent
Electronic Reports on Disk
Reports on Web
Year of Expiration - 2014 / 2015 / 2016 / 2017 Earliest
09/02/14
09/17/03
09/02/14
5-663-169
04/28/15
04/26/01
04/28/15
5-744-496
06/16/15
06/16/15
06/16/15
5-767-251
03/24/15
05/18/98
03/24/15
5-731-296
06/16/15
09/23/01
06/16/15
5-766-573
06/16/15
09/23/01
06/16/15
5-766-573
10/23/16
05/14/03
10/23/16
5-733-919
Class 1 -<10m ; Class 2 -<25m ; Class 3 -<50m ; Class 4 -<75m ; Class 5 -<100m Class 6 ->100m
This Drugs OFF Patent Series will be continued annually:- 2000
2001
2003
Drugs Off-Patent Report - less than 100 m

Source: http://www.locumusa.com/pdf/members/under100-1299.pdf